News Cortexyme Announces Clinical Hold on Atuzaginstat’s Investigational New Drug Application By MacKenzie Lahar | News
EventsNews Cortexyme’s Atuzaginstat Slowed Cognitive Decline in Participants with Alzheimer’s Disease and P. Gingivalis Infection in Phase 2/3 GAIN Trial: Additional Top-line Data Presented at CTAD 2021 By MacKenzie Lahar | Events, News
EventsNews Cortexyme Reports GAIN Trial Data Demonstrated Relationship Between Reduction of P. gingivalis Infection and Slowing of Alzheimer’s Disease Progression By MacKenzie Lahar | Events, News
